Cervical cancer screening involves cytological and virological assays to detect abnormal cells or high-risk HPV DNA. According to Dr. Shikha, clinicians use speculum-assisted sampling to collect cervical epithelial cells, which are analysed cytogenetically and virologically to identify precancerous changes, improving early detection sensitivity and preventive action.